Now Reading: Zebrafish study points to drug targets for spinal disc disease
-
01
Zebrafish study points to drug targets for spinal disc disease
A study using zebrafish has linked changes in gene activity to mineral build-up and hardening of spinal discs, a major feature of intervertebral disc degeneration. Researchers from the universities of Edinburgh and…
The Story in Brief
A study using zebrafish has linked changes in gene activity to mineral build-up and hardening of spinal discs, a major feature of intervertebral disc degeneration. Researchers from the universities of Edinburgh and Bristol found that fish lacking one copy of a collagen IX-related gene developed spinal changes resembling human disc disease, including fused vertebrae and hardened tissue.
The study, published in Communications Biology, identified disruptions in phosphate and fat metabolism, mTOR activity and vitamin A signalling. Bisphosphonates, osteoporosis medicines, blocked mineral build-up in the fish, while restricted feeding and drugs affecting fat metabolism reduced spinal fusions. The findings may support future non-surgical treatments, but they have not yet been proven in humans. Surgery remains the main long-term option for severe disc disease.
The Indian Opinion
Calling this a back-pain cure would be premature, just as dismissing animal research as irrelevant would be lazy. The study offers a biological explanation and possible drug targets, not evidence that existing osteoporosis medicines will treat people with disc degeneration. The real test is whether these pathways work safely in human cells and clinical trials, with measurable improvement in pain, movement and surgery rates.
Source: rediff.com
This story was synthesised by AI from the source linked above.
